Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study
- PMID: 26870257
- PMCID: PMC4727098
- DOI: 10.3892/ol.2015.3958
Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study
Abstract
Previous studies have indicated that complex interactions among viral, environmental and genetic factors lead to hepatocellular carcinoma (HCC). To identify susceptibility alleles for hepatitis B virus (HBV)-related HCC, the present study conducted a pilot two-phase genome-wide association study (GWAS) in 660 Han Chinese individuals. In phase 1, a total of 500,447 single-nucleotide polymorphisms (SNPs) were genotyped in 50 HCC cases and 50 controls using Affymetrix GeneChip 500k Array Set. In phase 2, 1,152 SNPs were selected from phase 1 and genotyped in 282 cases and 278 controls using the Illumina GoldenGate platform. The prior probability of HCC in control subjects was assigned at 0.01, and false-positive report probability (FPRP) was utilized to evaluate the statistical significance. In phase 1, one SNP (rs2212522) showed a significant association with HCC (Pallele=5.23×10-8; ORallele=4.96; 95% CI, 2.72-9.03). In phase 2, among 27 SNPs with unadjusted Pallele<0.05, 9 SNPs were associated with HCC based on FPRP criteria (FPRP <0.20). The strongest statistical evidence for an association signal was with rs2120243 (combined ORallele=1.76; 95% CI, 1.39-2.22; P=2.00×10-6), which maps within the fourth intron of VEPH1. The second strongest statistical evidence for an association was identified for rs1350171 (combined ORallele=1.66; 95% CI, 1.33-2.07; P=6.48×10-6), which maps to the region downstream of the FZD4 gene. The other potential susceptibility genes included PCDH9, PRMT6, LHX1, KIF2B and L3MBTL4. In conclusion, this pilot two-phase GWAS provides the evidence for the existence of common susceptibility loci for HCC. These genes involved various signaling pathways, including those associated with transforming growth factor β, insulin/phosphoinositide 3 kinase, Wnt and epidermal growth factor receptor. These associations must be replicated and validated in larger studies.
Keywords: hepatitis B virus; hepatocellular carcinoma; single-nucleotide polymorphisms.
Figures
Similar articles
-
TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.Biochem Genet. 2019 Feb;57(1):117-128. doi: 10.1007/s10528-018-9882-5. Epub 2018 Aug 2. Biochem Genet. 2019. PMID: 30073579
-
Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.Oncotarget. 2016 Jul 12;7(28):44076-44083. doi: 10.18632/oncotarget.9854. Oncotarget. 2016. PMID: 27286450 Free PMC article.
-
A Genetic Variant of PPP1CB Influences Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Chinese: A Pathway Based Analysis.J Hepatocell Carcinoma. 2021 Sep 2;8:1055-1064. doi: 10.2147/JHC.S321939. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34513747 Free PMC article.
-
Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.Infect Genet Evol. 2014 Oct;27:77-82. doi: 10.1016/j.meegid.2014.07.001. Epub 2014 Jul 8. Infect Genet Evol. 2014. PMID: 25010264
-
Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.BMC Med Genet. 2019 Aug 16;20(1):142. doi: 10.1186/s12881-019-0871-2. BMC Med Genet. 2019. PMID: 31419949 Free PMC article. Review.
Cited by
-
MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.Bioengineered. 2021 Dec;12(2):12568-12582. doi: 10.1080/21655979.2021.2010383. Bioengineered. 2021. PMID: 34903122 Free PMC article.
-
Genetic variants of cell cycle pathway genes predict disease-free survival of hepatocellular carcinoma.Cancer Med. 2017 Jul;6(7):1512-1522. doi: 10.1002/cam4.1067. Epub 2017 Jun 22. Cancer Med. 2017. PMID: 28639733 Free PMC article.
-
Genetic alterations in hepatocellular carcinoma: An update.World J Gastroenterol. 2016 Nov 7;22(41):9069-9095. doi: 10.3748/wjg.v22.i41.9069. World J Gastroenterol. 2016. PMID: 27895396 Free PMC article. Review.
-
Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.Medicine (Baltimore). 2017 Mar;96(12):e6127. doi: 10.1097/MD.0000000000006127. Medicine (Baltimore). 2017. PMID: 28328801 Free PMC article.
-
Ventricular Zone Expressed PH Domain Containing 1 (VEPH1): an adaptor protein capable of modulating multiple signaling transduction pathways during normal and pathological development.Cell Commun Signal. 2019 Sep 9;17(1):116. doi: 10.1186/s12964-019-0433-4. Cell Commun Signal. 2019. PMID: 31500637 Free PMC article. Review.
References
-
- Trinchet JC, Alperovitch A, Bedossa P, Degos F, Hainaut P, Beers BV. Epidemiology, prevention, screening and diagnosis of hepatocellular carcinoma. Bull Cancer. 2009;96:35–43. (In French) - PubMed
-
- Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, et al. Asian Oncology Summit: Management of hepatocellular carcinoma in Asia: Consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 2009;10:1111–1118. doi: 10.1016/S1470-2045(09)70241-4. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials